Type: Poster
Kenny Tang, MBBS, FRACP, FRCPA1*, Dawn Maze, MD, FRCPC, MSc2, Karen Yee, MD3,4, Hassan Sibai, MBBS, MD5*, Marta B. Davidson, MD, PhD6, Steven M. Chan, MD, PhD3,6, Aaron D. Schimmer, MD, PhD7, Andre C. Schuh, MD3, Aniket Bankar, MBBS, MD, DM6, Guillaume Richard-Carpentier, MD, FRCPC2, Anne Tierens, MD, PhD8, Mark D. Minden, MD, PhD9, Vikas Gupta, MD, FRCP, FRCPath7, Jeffrey H. Lipton10,11 and Dennis Kim, MD, PhD9,12
1Princess Margaret Cancer Centre, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
2Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
3Department of Medicine, University of Toronto, Toronto, ON, Canada
4Princess Margaret Cancer Centre, Toronto, ON, Canada
5Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
6Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
7Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
8Laboratory Medicine Program, University Health Network, Toronto, ON, Canada
9Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
10Hans Messner Allogenic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
11Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON, Canada
12Princess Margaret Cancer Centre, University of Toronto, Messner Allogeneic Blood and Marrow Transplantation Program, Toronto, ON, Canada
Xiaoshuai Zhang1*, Zongru Li2*, Ya-Zhen Qin3*, Robert Peter Gale4,5, Yueyun Lai6*, Hongxia Shi1*, Xiao Jun Huang, MD1,3,7,8,9,10,11,12,13,14,15,16,17 and Qian Jiang1,2,3,18,19,20,21,22*
1Peking University People's Hospital, Beijing, China
2Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China
3Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
4Haematology Research Center, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, UK, London, United Kingdom
5Centre for Haematology Research, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
6Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China
7National Clinical Research Center for Hematologic Disease, Beijing, China
8Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
9Peking-Tsinghua Centre for Life Science, Beijing, China
10Beijing Engineering Lab for Cellular Therapy, Beijing, China
11Peking University People’s Hospital, Peking University Institute of Hematology,National Clinical Research Center for Hematologic Disease, Beijing, China
12Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China
13Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
14Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
15Peking University People's Hospital,Peking University Institute of Hematology, Beijing, China
16Collaborative Innovation Center of Hematology, Peking University, Beijing, China
17Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
18Peking University People's Hospital, Beijing, CHN
19Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China
20Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, CHN
21Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, BEIJING, China
22Peking University Institute of Hematology, Peking University People's Hospital, Beijing, Beijing, China
Fabio Stagno, MD, PhD1, Elisabetta Abruzzese, MD2, Alessandra Iurlo, MD, PhD3*, Fabrizio Pane, MD4, Imma Attolico, MD5*, Paolo Sportoletti, MD6*, Patrizia Pregno7*, Sara Galimberti, MD8*, Barbara Scappini, MD9*, Maurizio Miglino, MD, PhD10*, Sergio Siragusa, MD11, Isabella Capodanno, MD12*, Diletta Valsecchi, MSc13*, Aurelio Pio Nardozza, PhD13*, Paola Coco, MD13*, Gianantonio Rosti, MD14*, Giuseppe Saglio, MD, PhD15 and Massimo Breccia, MD16*
1Hematology Unit, AOU Policlinico “Rodolico – San Marco” Rodolico Hospital, Catania, Catania, Italy
2S. Eugenio Hospital, Tor Vergata University, Rome, Roma, Italy
3Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
4Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy
5Department of Emergency and Organ Transplantation (D.E.T.O.), University of Bari, Bari, Italy
6Institute of Hematology and Center of Hemato-Oncology Research (CREO), University of Perugia, Perugia, Italy
7Hematology Unit, Az Ospedaliero Universitaria Città' della Salute e della Scienza, Turin, Italy
8Section of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Azienda ospedaliera Pisana, Pisa, Italy
9AOU Careggi, Florence, Italy
10IRCCS San Martino Hospital, Genoa, Italy
11Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PRO.MI.SE), University of Palermo, Palermo, Italy
12Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy
13Novartis Farma SpA, Origgio, Italy
14IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
15University of Turin, Dept. of Clinical and Biological Sciences, Orbassano, Italy
16Division of Hematology, Department of Translational and Precision Medicine, Azienda Policlinico Umberto I, Sapienza University, Rome, Italy
Jerald P. Radich, MD1, Chung Hoow Kok, BSc, PhD2*, Ekaterina Yu. Chelysheva, MD, PhD3*, Jorge E. Cortes, MD4, Qian Jiang5, Michael Mauro, MD6, Dragana Milojkovic, FRCPath, PhD7*, Beatriz Moiraghi, MD8*, Franck E. Nicolini, MD, PhD9, Matilda Ongondi, MD10*, Katia B Pagnano, MD, PhD11, Daniela Žácková, MD, PhD12*, Delphine Rea, MD, PhD13, Nicola Evans, BSc14* and Timothy Hughes, MD, MBBS, FRACP, FRCPA15,16
1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
2Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia
3National Medical Research Center for Hematology, Moscow, AZ
4Georgia Cancer Center, Augusta, GA
5Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
6Memorial Sloan Kettering Cancer Center, New York, NY
7Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
8Hospital General De Agudos J.M. Ramos Mejia, Buenos Aires, Argentina
9Centre Hospitalier Lyon Sud, LYON Cedex 03, France
10Kenyatta National Hospital, Nairobi, KEN
11Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil
12Internal Hematology and Oncology Clinic, University Hospital Brno and Masaryk University, Brno, Czech Republic
13Université de Paris, Hematology department, Saint-Louis hospital, APHP, Paris, France
14International CML Foundation, Bexhill On Sea, VIC, United Kingdom
15South Australian Health and Medical Research Institute SAHMRI, Adelaide, SA, Australia
16International CML Foundation, Bexhill on Sea, United Kingdom
Xiaoshuai Zhang1*, Bingcheng Liu2*, Jian Huang3*, Gongli Zhang4,5*, Xiaoli Liu6,7*, Na Xu7*, Weiming Li8*, Xin Du9*, Jianyu Weng, MD10,11,12,13, Hai Lin14*, Rong Liang15*, Chunyan Chen, PhD16*, Huanling Zhu17*, Ling Pan, MD, PhD18,19,20*, Yunfan Yang21*, Xiaodong WANG, MD22*, Guohui Li23*, Zhuogang Liu, MD24*, Zhenfang Liu25*, Jianda Hu26,27,28,29,30,31,32, Chunshui Liu33*, Li Fei34,35,36,37,38,39, Wei Yang40*, Li Meng41*, Robert Peter Gale42,43, Xiao Jun Huang, MD1,44,45,46,47,48,49,50,51,52,53,54,55 and Qian Jiang1,46,56,57,58,59,60,61*
1Peking University People's Hospital, Beijing, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, China
3The Fourth Affiliated Hospital Zhejiang University School of Medicine, Yiwu, China
4Henan Cancer Hospital, Zhengzhou, China
5Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
6Department of Hematology, Nanfang Hospital,Southern Medical University, Guangzhou, China
7Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
8Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
9Department of Hematology, Shenzhen Second People's Hospital, Guangdong, China, Shenzhen, China
10Guangdong general hospital/Guangdong Academay of Medical Sciences, GUANGZHOU, China
11Guangdong General Hospital, Guangzhou, China
12Department of Hematology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
13Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
14Department of Hematology and Oncology, Jilin University First Hospital, Jilin, China., Jilin, China
15Department of Hematology, Xijing Hospital, Air Force Medical University, Xi'an, China, Xi'an, China
16Department of Hematology, Qilu Hospital, Shandong University School of Medicine, Jinan, P,R, China, Jinan, Shandong, CHN
17Department of Hematology, West China Hospital of Sichuan University, Chengdu Sichuan, China, Sichuan, China
18Department of Hematology, West China Hospital,Sichuan University, Chengdu, China
19Department of Hematology and Hematology Research Laboratory , West China Hospital, Sichuan University, Chengdu, China
20West China Hospital of Sichuan University, Chengdu, China
21Department of Hematology, West China Hospital of Sichuan University, Chengdu Sichuan, China, Chengdu, CHN
22Sichuan Provincial People’s Hospital, Affliated Hospital of University of Electronic Science and Technology of China, Chengdu, CHN
23Department of Hematology, Tangdu Hospital, Fourth Military Medical University, Baqiao District, Xinshi Road No1, Xi'an, 710038, China., Xi'an, China
24Shengjing Hospital of China Medical University, Shenyang, China
25Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
26Department of Hematology, Fujian Medical University Union Hospital,Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fuzhou, China
27Department of Hematology, Union Hospital, Fujian Medical University, Fuzhou, China
28Fujian Medical University Union Hospital, Fuzhou, Fujian, China
29Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
30Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
31Department of Hematology, Union Hospital, Fujian Institute of Hematology, Fuzhou, China
32Department of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
33Department of Hematology, The First Hospital of Jilin University, Changchun., Changchun, China
34Institute of Lymphoma and Myeloma, Nanchang University, Nanchang, China, Nanchang, China
35The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China
36Department of Hematology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China 2 Depart, Nanchang, CHN
37the First Affiliated Hospital of Nanchang University, Nanchang, China
38Jiangxi Key Laboratory of Molecular Diagnosis and Precision Medicine, the First Affiliated Hospital of Nanchang University, Nanchang, China
39Jiangxi Clinical Research Center for Hematologic Disease, Nanchang, China
40Department of Hematology, Shengjing Hospital of China Medical University, Liaoning, China, Liaoning, China
41Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
42Haematology Research Center, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, UK, London, United Kingdom
43Centre for Haematology Research, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
44National Clinical Research Center for Hematologic Disease, Beijing, China
45Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
46Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
47Peking-Tsinghua Centre for Life Science, Beijing, China
48Beijing Engineering Lab for Cellular Therapy, Beijing, China
49Peking University People’s Hospital, Peking University Institute of Hematology,National Clinical Research Center for Hematologic Disease, Beijing, China
50Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China
51Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
52Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
53Peking University People's Hospital,Peking University Institute of Hematology, Beijing, China
54Collaborative Innovation Center of Hematology, Peking University, Beijing, China
55Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
56Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, CHN
57Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China
58Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China
59Peking University People's Hospital, Beijing, CHN
60Peking University Institute of Hematology, Peking University People's Hospital, Beijing, Beijing, China
61Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, BEIJING, China
Michael Mauro, MD1, Ronald Paquette, MD2, Rüdiger Hehlmann, MD3, Loretta A. Williams, PhD, MSN, BSN, BA4, Stuart L. Goldberg, M.D.5, Mauricette Michallet6, Carlo Gambacorti-Passerini, MD7, Derek Tang, PhD8*, Irene S. DeGutis8*, Ali McBride8, Lori Parsons9*, Monica Z. Montelongo9* and Jorge E. Cortes, MD10
1Memorial Sloan-Kettering Cancer Center, New York, NY
2Cedars-Sinai Medical Center, Los Angeles, CA
3Universität Heidelberg, Heidelberg, Germany
4The University of Texas MD Anderson Cancer Center, Houston, TX
5John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
6Centre de Lutte Contre le Cancer Léon Bérard, Lyon, France
7University of Milano-Bicocca, Milan, Italy
8Bristol Myers Squibb, Princeton, NJ
9ICON plc, Blue Bell, PA
10Georgia Cancer Center, Augusta University, Augusta, GA
Aram Bidikian1*, Hagop Kantarjian, MD2, Ghayas C. Issa, MD1, Farhad Ravandi, MD1, Guillermo Garcia-Manero, MD3, Gautam Borthakur, MD1, Tapan M. Kadia, MD4, Naval Daver, MD1, Nitin Jain, MD4, Naveen Pemmaraju, MD1, Courtney D. DiNardo, MD, MSCE1, Fadi Haddad, MD1*, Sherry A. Pierce, BSN, BA1*, Elias Jabbour, MD1 and Koji Sasaki, MD1
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, MD Anderson Cancer Center, Houston, TX
Alon Rozental, MD1,2*, Erez Halperin1*, Chiya Leibovitch, MD3*, Merav Barzilai, MD2,4*, Uri Rozovski, MD1,2, Pia Raanani, MD1,2 and Adi Shacham Abulafia, MD2,5*
1Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
2Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
3Internal Medicine B, Samson Assuta, Ashdod Hospital, Ashdod, Israel
4Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
5Rabin Medical Center, Petah-Tikva, Israel
Kathy Dominy, BSc PhD1*, Matthew Salmon, BSc PhD2*, Richard Szydlo, BSc, PhD3*, Chloe Hayden, BSc1*, Helen E White, BSc PhD2*, Mary Alikian, BSc PhD1*, Dragana Milojkovic, FRCPath, PhD3*, Mhairi Copland, MD PhD4*, Letizia Foroni, MD, PhD3*, Nicholas C.P. Cross, PhD5, Richard E Clark6* and Jane F. Apperley, FRCP, FRCPath, MB3
1North West London Pathology, Imperial College Healthcare NHS Trust, London, United Kingdom
2Salisbury NHS Foundation Trust, Salisbury, United Kingdom
3Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
4Paul O'Gorman Leukemia Research Centre, University of Glasgow, Glasgow, United Kingdom
5Faculty of Medicine, University of Southampton, Southampton, United Kingdom
6Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom
Shiwei Hu1,2*, Chen DAN1*, Xiaoqiong Zhu1* and Jian Huang, MD, PhD1,2,3
1Department of Hematology, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, China
2Department of Hematology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
3Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, China
Massimo Breccia, MD1*, Anna Turkina, MD2*, Carla Boquimpani, MD3*, Charles Chuah, MD4*, Giora Sharf5,6*, Luigi Di Caprio, MD, PhD7*, Matthias Hoch, PhD8*, Justin Yssel, PhD9*, Yifan Zhang, PhD10* and Andreas Hochhaus, MD11
1Division of Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
2Haematology Research Centre, Moscow, Russia
3HEMORIO, State Institute of Hematology Arthur de Siquiera Cavalcanti, Rio de Janeiro, Brazil
4Singapore General Hospital, Duke-NUS Medical School, Singapore, Singapore
5CML Advocates Network, Bern, Switzerland
6Israeli CML Patients Organization, Netanya, Israel
7Novartis Pharma SpA, Origgio, Italy
8Novartis Institute for BioMedical Research, Basel, Switzerland
9Novartis Ireland Limited, Dublin, Ireland
10Novartis Pharmaceuticals Corporation, East Hanover, NJ
11Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany
Xiaoshuai Zhang1*, Bingcheng Liu2*, Jian Huang3*, Gongli Zhang4,5*, Xiaoli Liu6,7*, Na Xu7*, Weiming Li8*, Xin Du9*, Jianyu Weng, MD10,11,12,13, Hai Lin14*, Rong Liang15*, Chunyan Chen, PhD16*, Huanling Zhu17*, Ling Pan, MD, PhD18,19*, Yun-fan Yang, MD20*, Xiaodong WANG, MD21*, Guohui Li22*, Zhuogang Liu, MD23*, Zhenfang Liu24*, Jianda Hu25,26,27,28,29, Chunshui Liu30*, Li Fei31,32,33, Wei Yang34*, Li Meng35*, Robert Peter Gale36,37, Xiao Jun Huang, MD1,38,39,40,41,42,43,44,45,46,47,48,49 and Qian Jiang40,50,51,52,53,54,55*
1Peking University People's Hospital, Beijing, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, China
3The Fourth Affiliated Hospital Zhejiang University School of Medicine, Yiwu, China
4Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
5Henan Cancer Hospital, Zhengzhou, China
6Department of Hematology, Nanfang Hospital,Southern Medical University, Guangzhou, China
7Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
8Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
9Department of Hematology, Shenzhen Second People's Hospital, Guangdong, China, Shenzhen, China
10Guangdong general hospital/Guangdong Academay of Medical Sciences, GUANGZHOU, China
11Guangdong General Hospital, Guangzhou, China
12Department of Hematology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
13Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
14Department of Hematology and Oncology, Jilin University First Hospital, Jilin, China., Jilin, China
15Department of Hematology, Xijing Hospital, Air Force Medical University, Xi'an, China, Xi'an, China
16Department of Hematology, Qilu Hospital, Shandong University School of Medicine, Jinan, P,R, China, Jinan, Shandong, CHN
17Department of Hematology, West China Hospital of Sichuan University, Chengdu Sichuan, China, Sichuan, China
18Department of Hematology, West China Hospital,Sichuan University, Chengdu, China
19Department of Hematology and Hematology Research Laboratory , West China Hospital, Sichuan University, Chengdu, China
20Department of Hematology, West China Hospital, Sichuan University, Chengdu, China
21Sichuan Provincial People’s Hospital, Affliated Hospital of University of Electronic Science and Technology of China, Chengdu, CHN
22Department of Hematology, Tangdu Hospital, Fourth Military Medical University, Baqiao District, Xinshi Road No1, Xi'an, 710038, China., Xi'an, China
23Shengjing Hospital of China Medical University, Shenyang, China
24Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
25Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
26Department of Hematology, Fujian Medical University Union Hospital,Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fuzhou, China
27Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
28Department of Hematology, Union Hospital, Fujian Institute of Hematology, Fuzhou, China
29Department of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
30Department of Hematology, The First Hospital of Jilin University, Changchun., Changchun, China
31The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China
32Department of Hematology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China 2 Depart, Nanchang, CHN
33Jiangxi Key Laboratory of Molecular Diagnosis and Precision Medicine, the First Affiliated Hospital of Nanchang University, Nanchang, China
34Department of Hematology, Shengjing Hospital of China Medical University, Liaoning, China, Liaoning, China
35Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
36Haematology Research Center, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, UK, London, United Kingdom
37Centre for Haematology Research, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
38National Clinical Research Center for Hematologic Disease, Beijing, China
39Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
40Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
41Peking-Tsinghua Centre for Life Science, Beijing, China
42Beijing Engineering Lab for Cellular Therapy, Beijing, China
43Peking University People’s Hospital, Peking University Institute of Hematology,National Clinical Research Center for Hematologic Disease, Beijing, China
44Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Beijing, China
45Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
46Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
47Peking University People's Hospital,Peking University Institute of Hematology, Beijing, China
48Collaborative Innovation Center of Hematology, Peking University, Beijing, China
49Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
50Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China
51Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, CHN
52Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China
53Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, BEIJING, China
54Peking University People's Hospital, Beijing, CHN
55Peking University Institute of Hematology, Peking University People's Hospital, Beijing, Beijing, China
Sashi Kant Singh, MD*, Karthik Kumar, MD*, Jhasaketan Nayak, MD*, Jasmine Porwal, MD*, Sikha Morang, M. TECH*, Gaurav Dhingra, MD, DNB* and Uttam Kumar Nath, MD, DM
Department of Medical Oncology and Hematology, All India Institute of Medical Sciences (AIIMS), Rishikesh, India
Gianantonio Rosti, MD1*, Giuseppe Saglio, MD, PhD2, Fabio Stagno, MD, PhD3, Diletta Valsecchi, MSc4*, Aurelio Pio Nardozza, PhD4*, Paola Coco, MD4*, Massimo Breccia, MD5* and Alessandra Iurlo, MD, PhD6*
1IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
2University of Turin, Dept. of Clinical and Biological Sciences, Orbassano, Italy
3Hematology Unit, AOU Policlinico “Rodolico – San Marco” Rodolico Hospital, Catania, Catania, Italy
4Novartis Farma SpA, Origgio, Italy
5Division of Hematology, Department of Translational and Precision Medicine, Azienda Policlinico Umberto I, Sapienza University, Rome, Italy
6Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
Katia B Pagnano, MD, PhD1, Ana Beatriz Pascoal Lopes1*, Eliana C M Cristina Martins Miranda, PhD, MEd1*, Marcia Delamain, MD, PhD2*, Gislaine B O Duarte, MD1*, Samuel de Souza Medina, MD, MSc1*, Fernando Vieira Pericole, MD, PhD1, Guilherme Brasil Duffles Amarante, MD1*, Bruno K Duarte, MD, PhD1*, Graziele Pavan1*, Isabella Macedo Toni, MSc3*, Erich V De Paula, MD, PhD1 and Carmino Antonio Souza, MD, PhD1*
1Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil
2Faculdade de Medicina de Minas Gerais – FCMMG-MG, Belo Horizonte, Brazil
3Hematology and Hemotherapy Center, University of Campinas - UNICAMP, Campinas, AC, Brazil
Jorge E. Cortes, MD1, Qian Jiang2*, Jianxiang Wang, MD3, Jianyu Weng, MD4, Huanling Zhu5*, Xiaoli Liu6*, Andreas Hochhaus, MD7, Dong-Wook Kim, M.D., Ph.D.8, Jerald Radich9*, Michael R. Savona, MD10, Patricia Martin-Regueira, MD11*, Oumar Sy, PhD11* and Giuseppe Saglio, MD, PhD12
1Georgia Cancer Center, Augusta, GA
2Peking University People's Hospital, Beijing, China
3Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China
4Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
5West China Hospital of Sichuan University, Chengdu, China
6Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
7Univerisitätsklinikum Jena, Jena, Germany
8Uijeongbu Eulji Medical Center, Geumo-dong, Uijeongbu-si, Korea, Republic of (South)
9Fred Hutchinson Cancer Center, Seattle, WA
10Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN
11Bristol Myers Squibb, Princeton, NJ
12University of Turin, Turin, Italy
Elzbieta Szczepanek, MD1,2*, Ositadima Chukwu, MD1*, Brygida Marczyk, MSc3*, Stefan Chłopicki, MD, PhD3* and Tomasz Sacha, MD, PhD1*
1Department of Hematology, Jagiellonian University Medical College, Krakow, Poland
2Doctoral School in Medical Sciences and Health Sciences, Jagiellonian University Medical College, Krakow, Poland
3Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland
Hans Lennernäs, PhD1*, Charlotta Liljebris, PhD2*, Magnus Brisander, PhD2*, Gérald Jesson, PhD2*, Per Andersson, PhD2*, Gunnar Larfors3* and Leif Stenke, MD, PhD4
1Department of Pharmaceutical Biosciences, Translational Drug Discovery and Development, Uppsala University, Uppsala, Sweden
2Xspray Pharma, Solna, Sweden
3Department of Medical Sciences , Unit of Hematology, Uppsala Univeristy, Uppsala, Sweden
4Department of Hematology, Theme Cancer and Department of Medicine Solna, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, Sweden
Anna Turkina, MD1*, Elena A. Kuzmina2*, Elza Lomaia, MD, PhD3*, Elena Morozova, MD, PhD4*, Oleg A. Shukhov, MD, PhD5*, Anna N. Petrova, MD6*, Tamara Chitanava7*, Julia J. Vlasova8*, Ekaterina Yu. Chelysheva, MD, PhD9*, Evgeniya Sbityakova, MD7*, Irina S. Nemchenko, MD, PhD6*, Anastasiya V. Bykova, MD6*, Margarita A. Gurianova, MD1*, Alina V. Kokhno, MD, PhD1* and Elena N. Parovichnikova, MD, PhD10*
1National Medical Research Center for Hematology, Moscow, Russian Federation (Russia), Moscow, Russian Federation
2National Medical Research Center for Hematology, Moscow, AL, Russia
3Almazov National Medical Research Centre, St. Petersburg, Russian Federation
4RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russian Federation
5National Medical Research Center for Hematology, Moscow, Russia
6National Medical Research Center for Hematology, Moscow, Russian Federation
7Almazov National Medical Research Centre, Saint-Petersburg, Russian Federation
8RM Gorbacheva Research Institute, Pavlov First Saint Petersburg State Medical University, Saint-Petersburg, Russian Federation
9National Medical Research Center for Hematology, Moscow, AZ
10Intensive high-dosage chemotherapy department of hemoblastosis and hematopoiesis depressions, National Research Center for Hematology, Moscow, Russian Federation
Franck E. Nicolini, MD, PhD1,2, Francoise Huguet, MD2,3*, Lynn Huynh4*, Churong Xu, MHS4*, Christophe Bouvier, MS1,2*, Aurore Yocolly, MPH, MS, MBA5* and Gabriel Etienne, MD, PhD2,6*
1Centre Léon Bérard, Lyon, France
2Fi-LMC group, Lyon, France
3Institut Universitaire du Cancer, CHU, Toulouse, France
4Analysis Group, Inc., Boston, MA
5Novartis Services, Inc., East Hanover, NJ
6Institut Bergonié, Bordeaux, France